Amphastar Pharmaceuticals, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Amphastar Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2024 was 22.9 %, a 4.22% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2023 was 23.2 %, a 27.7% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2022 was 18.2 %, a 31.1% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Return On Equity for 2021 was 13.9 %, a 4256% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 23.2 +5.03 +27.7% Jan 1, 2023 Dec 31, 2023
2022 18.2 +4.31 +31.1% Jan 1, 2022 Dec 31, 2022
2021 13.9 +13.5 +4256% Jan 1, 2021 Dec 31, 2021
2020 0.32 -11.4 -97.3% Jan 1, 2020 Dec 31, 2020
2019 11.7 +13.4 Jan 1, 2019 Dec 31, 2019
2018 -1.7 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.